Byhealth Co., Ltd (SHE:300146)
China · Delayed Price · Currency is CNY 9.94
+0.09 (0.91%)
Oct 28, 2026, 1:15 PM CST
Byhealth Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,648 | 6,265 | 6,838 | 9,407 | 7,861 | 7,431 |
Revenue Growth | 10.43% | -8.38% | -27.30% | 19.66% | 5.79% | 21.93% |
Gross Profit Gross Profit Growth | 4,564 | 4,240 | 4,518 | 6,468 | 5,356 | 4,887 |
Operating Income Operating Income Growth | 783.93 | 891.54 | 744.04 | 1,847 | 1,561 | 1,797 |
Net Income Net Income Growth | 687.58 | 782.15 | 652.83 | 1,746 | 1,386 | 1,754 |
Earnings Per Share EPS Growth | 0.42 | 0.47 | 0.38 | 1.03 | 0.81 | 1.05 |
EPS Growth | 3.91% | 23.68% | -63.11% | 27.16% | -22.86% | 9.38% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
China China Growth | 5,079 | 5,734 | 7,938 | 6,713 | 6,621 |
Australia Australia Growth | 1,003 | 872.28 | 989.03 | 805.4 | 664.34 |
Hong Kong and Others Hong Kong and Others Growth | 321.03 | 337.58 | 550.94 | 407.48 | 315.21 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -137.61 | -105.51 | -70.87 | -64.42 | -169.68 |
Total Total Growth | 6,265 | 6,838 | 9,407 | 7,861 | 7,431 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,282 | 6,340 | 6,380 | 6,438 | 5,631 | 5,905 |
Total Debt Total Debt Growth | 1,184 | 1,032 | 1,543 | 174.17 | 24.25 | 73.99 |
Net Cash (Debt) Net Cash Growth | 4,098 | 5,308 | 4,836 | 6,264 | 5,607 | 5,831 |
Net Cash Growth | -10.22% | 9.75% | -22.79% | 11.72% | -3.85% | 81.81% |
Net Cash Per Share Net Cash Per Share Growth | 2.48 | 3.19 | 2.82 | 3.69 | 3.28 | 3.49 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 591.13 | 1,214 | 685.94 | 2,051 | 1,379 | 1,819 |
Capital Expenditures CapEx Growth | -121.37 | -133.38 | -305.75 | -1,257 | -244.78 | -263.16 |
Free Cash Flow Free Cash Flow Growth | 469.76 | 1,080 | 380.19 | 794.08 | 1,134 | 1,556 |
Free Cash Flow Growth | -56.37% | 184.15% | -52.12% | -29.98% | -27.10% | 25.00% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.65% | 67.67% | 66.06% | 68.76% | 68.13% | 65.76% |
Operating Margin | 11.79% | 14.23% | 10.88% | 19.63% | 19.86% | 24.18% |
Pretax Margin | 13.20% | 16.09% | 13.17% | 23.34% | 21.69% | 29.31% |
Profit Margin | 10.34% | 12.48% | 9.55% | 18.56% | 17.63% | 23.60% |
FCF Margin | 7.07% | 17.24% | 5.56% | 8.44% | 14.43% | 20.94% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.450 | 0.450 | 0.360 | 0.900 | 0.180 | 0.700 |
Dividend Per Share Growth | 25.00% | 25.00% | -60.00% | 400.00% | -74.29% | 0% |
Dividend Yield | 4.53% | 3.75% | 2.99% | 5.29% | 0.79% | 2.60% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.86 | 25.72 | 31.10 | 16.59 | 28.00 | 26.14 |
Forward PE | 23.76 | 23.32 | 18.95 | 14.10 | 20.65 | 22.41 |
P/FCF Ratio | 35.12 | 18.62 | 53.41 | 36.48 | 34.21 | 29.46 |
PS Ratio | 2.48 | 3.21 | 2.97 | 3.08 | 4.94 | 6.17 |